Treatment of hydrocephalus following posterior fossa tumor resection: a multicenter collaboration from the Hydrocephalus Clinical Research Network.
Dewan MC, Isaacs AM, Cools MJ, Yengo-Kahn A, Naftel RP, Jensen H, Reeder RW, Holubkov R, Haizel-Cobbina J, Riva-Cambrin J, Jafrani RJ, Pindrik JA, Jackson EM, Judy BF, Kurudza E, Pollack IF, Mcdowell MM, Hankinson TC, Staulcup S, Hauptman J, Hall K, Tamber MS, Cheong A, Warsi NM, Rocque BG, Saccomano BW, Snyder RI, Kulkarni AV, Kestle JRW, Wellons JC 3rd; Hydrocephalus Clinical Research Network.
Dewan MC, et al.
J Neurooncol. 2023 May;163(1):123-132. doi: 10.1007/s11060-023-04316-4. Epub 2023 May 2.
J Neurooncol. 2023.
PMID: 37129738
Free PMC article.
Children who experienced hydrocephalus secondary to PFBT from 2008 to 2021 were included. ...No ETV failures were identified beyond 3 years, while shunt failures occurred beyond 5 years. Shunt infections occurred in 5.5% of the VPS cohort. ...
Children who experienced hydrocephalus secondary to PFBT from 2008 to 2021 were included. ...No ETV failures were identified b …